Clinical meaning
Neonatal jaundice results from an imbalance between bilirubin production and conjugation/excretion that is physiologically exaggerated in the newborn period. Neonates produce bilirubin at approximately twice the adult rate because of higher red blood cell mass (hematocrit 50-65%), shorter RBC lifespan (70-90 days versus 120 days in adults), and greater enterohepatic circulation of bilirubin. Simultaneously, the neonatal liver has limited conjugation capacity: UDP-glucuronosyltransferase (UGT1A1) activity is only 1% of adult levels at birth, reaching mature capacity by 14 weeks of age. Unconjugated (indirect) bilirubin is lipophilic and circulates bound to albumin; when the bilirubin-albumin binding capacity is exceeded (or albumin is displaced by drugs or acidosis), free unconjugated bilirubin crosses the blood-brain barrier and deposits in the basal ganglia, hippocampus, and cranial nerve nuclei, causing acute bilirubin encephalopathy (lethargy, hypotonia, high-pitched cry, opisthotonus) and potentially chronic bilirubin encephalopathy (kernicterus — permanent choreoathetoid cerebral palsy, sensorineural hearing loss, upward gaze palsy). The Bhutani hour-specific nomogram plots total serum bilirubin (TSB) against the neonate's age in hours and assigns a risk zone (low, low-intermediate, high-intermediate, or high risk) that guides the intensity of monitoring and determines phototherapy thresholds. Phototherapy uses blue-green light (wavelength 460-490 nm) that converts unconjugated bilirubin in the skin into water-soluble photoisomers (lumirubin and configurational isomers) through structural and configurational isomerization, allowing excretion in bile and urine without hepatic conjugation. Exchange transfusion is reserved for TSB approaching or exceeding 25 mg/dL (or lower thresholds in premature or hemolytic disease) to rapidly remove circulating bilirubin and antibody-coated RBCs, preventing kernicterus. Pathologic jaundice (appearing within 24 hours of birth, rising more than 5 mg/dL per day, or direct bilirubin greater than 1 mg/dL) requires urgent workup for hemolytic disease (ABO/Rh incompatibility, G6PD deficiency, hereditary spherocytosis) or cholestatic causes (biliary atresia, neonatal hepatitis).